Cardiac disorder

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
C Cardiology (ATC C) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Monoclonal antibody (immune, humanized) 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Rigshospitalet Academic
    DOBUTAMINE; TOCILIZUMAB
    2024-515999-13-00 1 country 2022 n=100
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Rigshospitalet Academic 1 Phase IV 0
New trials by year
2022
1
← All indication landscapes